✦ LIBER ✦

Intravitreal ranibizumab (Lucentis®) in the treatment of choroidal neovascular membrane secondary to punctate inner choroidopathy

✍ Scribed by A. Valverde Megías; P. Arriola Villalobos; J. Reche Frutos; J. Donate López; C. Calvo González; J. García Feijoo

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intravitreal ranibizumab in the treatmen

✍ Leung, Andrea K.; Weisbrod, Daniel J.; Schwartz, Carol 📂 Article 📅 2010 🏛 Canadian Ophthalmological Society 🌐 English ⚖ 273 KB

Intravitreal ranibizumab in the treatmen

✍ Jiménez, B.; Pinilla, I.; Cristóbal, J.A.; Mínguez, E.; Pérez, D.; Cruz, N.; Pei 📂 Article 📅 2014 🏛 Elsevier ⚖ 775 KB

Intravitreal Ranibizumab for the Treatme

✍ Shwu-Jiuan Sheu 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 794 KB

Analysis of Outcomes for Intravitreal Be

✍ Douglas A. Cionni; Shawn A. Lewis; Michael R. Petersen; Robert E. Foster; Christ 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 219 KB

Intravitreal Ranibizumab in the treatmen

✍ Lyall, D A M; Hutchison, B M; Gaskell, A; Varikkara, M 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 235 KB

Cost-Effectiveness of Ranibizumab for th

✍ Leteneux, C.; Claxton, L.; Malcolm, W.A.; Taylor, M.; Rathi, H. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB